News

  1. Catalent And Ethicann Sign Development And License Agreement For New Fast-Dissolve Cannabinoid-Based Treatments 1/12/2023

    Catalent, the global leader in enabling the development and supply of better treatments across multiple modalities, and Ethicann Pharmaceuticals Inc., a Canadian/U.S. specialty pharmaceutical company focused on the development of high-value cannabinoid drug therapies, today announced that the companies had executed a development and license agreement to develop Ethicann’s clinical drug pipeline using Catalent’s proprietary Zydis orally disintegrating tablet (ODT) technology.

  2. Argonaut Manufacturing Services Set To Expand Drug Product Fill/Finish Capabilities With Significant Capital Investment 1/10/2023

    Argonaut Manufacturing Services (‘Argonaut’), a contract manufacturing organization (CMO) serving the life sciences, molecular diagnostics, and biopharma industries, today announced a capital investment led by majority shareholder Telegraph Hill Partners that will be focused on expansion at their Carlsbad, CA, manufacturing facilities.

  3. Oncorus Announces Research Collaboration With Daewoong Pharmaceutical For The Development Of Lipid Nanoparticle Formulations For mRNA Drug Candidates 1/4/2023

    Oncorus, Inc. (Nasdaq: ONCR), an RNA medicines company focused on developing intravenously administered, self-amplifying RNA to transform outcomes for cancer patients, and Daewoong Pharmaceutical Co., Ltd. (KRX: 069620), a leading South Korean pharmaceutical company, today announced a research collaboration for the discovery and development of novel lipid nanoparticle (LNP) formulations for mRNA drug candidates.

  4. Berkshire Sterile Expands Analytical Testing And Development Services 12/19/2022

    Berkshire Sterile Manufacturing (BSM), a Massachusetts-based fill finish CDMO, recently purchased and validated three new analytical instruments to expand their testing and development capabilities.

  5. Formulated Solutions Signs Agreement To Acquire 455,000ft2 US FDA Approved Drug Production Site 12/19/2022

    Formulated Solutions, a Florida-based Contract Development and Manufacturing Organization (CDMO) supporting consumer-centric innovation, expert development, and cost-effective production of consumer healthcare solutions, announced an agreement to acquire a newly updated 455,000 ft2 FDA approved pharmaceutical liquids, semi solids, aerosol, BoV, and metered dose nasal spray production facility located in Cleveland, TN.

  6. Hovione And GEA Announce A Strategic Collaboration To Advance Continuous Tableting 12/14/2022

    Hovione and GEA today announced a strategic collaboration to advance Continuous Tableting. This partnership stemmed from a successful customer-supplier relationship spanning several years.

  7. Kindeva And Meridian Combine: Create Leading Drug-Device Combination Product CDMO 12/13/2022

    The combination has created a leading global contract development and manufacturing organization (“CDMO”) focused on drug-device combination products. The combination will operate under the Kindeva name, with Meridian operating as, “Meridian Medical Technologies, a Kindeva Company”.

  8. Gov. Whitmer Announces Pfizer Investing $750M To Expand U.S. Sterile Injectable Facility, Create 300 Jobs 12/5/2022

    Today Governor Gretchen Whitmer announced that Pfizer Inc. will be investing $750M in its Kalamazoo, Michigan facility, expanding production and creating 300 good-paying jobs. This investment aims to establish the facility as one of the most technologically advanced in the world and continue to ensure the uninterrupted supply of Pfizer medicines and vaccines.

  9. Datwyler Adds Steam Sterilization Option For Ready-To-Use Components For Injectable Drugs 12/1/2022

    Datwyler, a leading provider of high-quality, system-critical elastomer components, announces the launch of Steam Sterilization for Ready-to-Use components. This service is applicable to non-coated and coated solutions like OmniFlex® stoppers for vials and NeoFlexä plungers for prefilled syringes and cartridges. As part of the company’s “Quality First” approach to designing and producing these packaging components, Datwyler will deliver RTU components in robust packaging guaranteeing a shelf life of 2 years after steam sterilization.

  10. WuXi STA Launches Another Parenteral Formulation Manufacturing Line At Wuxi City Site 12/1/2022

    WuXi STA, a subsidiary of WuXi AppTec, today announced a new parenteral formulation manufacturing line has started operation at the drug product site in Wuxi city, China. It is the second line opened this year for parenteral drug product clinical and commercial manufacturing, with an annual capacity of 10 million units.